Foille (benzocaine 5 % / chloroxylenol 0.1 % ) Topical Ointment

benzocaine 0.05 MG/MG / chloroxylenol 0.001 MG/MG Topical Ointment [Foille]


Photofrin 75 MG (as porfimer sodium) Injection

porfimer sodium 75 MG Injection [Photofrin]


Oncaspar 3750 UNT per 5 ML Injection
ONCASPAR 3750 UNT in 5 ML Injection

5 ML pegaspargase 750 UNT/ML Injection [Oncaspar]


5-5-fluorouracil 50 MG/ML Topical Cream [Efudex]


Galzin 25 MG Oral Capsule
GALZIN 25 MG Oral Capsule

zinc acetate 25 MG Oral Capsule [Galzin]


Galzin 50 MG Oral Capsule
GALZIN 50 MG Oral Capsule

zinc acetate 50 MG Oral Capsule [Galzin]


TYZINE PEDIATRIC 0.05 % Nasal Solution
Tyzine 0.5 MG/ML Nasal Solution
Tyzine Pediatric 0.05 % Nasal Drops

tetrahydrozoline hydrochloride 0.5 MG/ML Nasal Solution [Tyzine]


Sulfoam 2 % Medicated Shampoo
Sulfoam 20 MG/ML Medicated Shampoo

sulfur 20 MG/ML Medicated Shampoo [Sulfoam]


acitretin 10 MG Oral Capsule [Soriatane]


acitretin 25 MG Oral Capsule [Soriatane]


Ex-Lax Regular Strength Chocolated 15 MG Chewable Tablet

sennosides, USP 15 MG Chewable Tablet [Ex-Lax Chocolated]


Ex-Lax Regular Strength 15 MG Oral Tablet

Ex-Lax Regular Strength Pills 15 MG Oral Tablet

sennosides, USP 15 MG Oral Tablet [Ex-Lax Regular Strength Pills]


Ex-Lax Maximum Strength 25 MG Oral Tablet

Ex-Lax Maximum Relief Formula 25 MG Oral Tablet

sennosides, USP 25 MG Oral Tablet [Ex-Lax Maximum Relief Formula]


Benzamycin (benzoyl peroxide 5 % / erythromycin 3 % ) Topical Gel

benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin]

Benzamycin (benzoyl peroxide 50 MG / erythromycin 30 MG) per GM Topical Gel


tiaGABine hydrochloride 4 MG Oral Tablet [Gabitril]

tiagabine hydrochloride 4 MG Oral Tablet [Gabitril]


tiaGABine hydrochloride 12 MG Oral Tablet [Gabitril]

tiagabine hydrochloride 12 MG Oral Tablet [Gabitril]


tiaGABine hydrochloride 16 MG Oral Tablet [Gabitril]

tiagabine hydrochloride 16 MG Oral Tablet [Gabitril]


lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [Combivir]

Combivir (lamiVUDine 150 MG / zidovudine 300 MG) Oral Tablet

Combivir (lamivudine 150 MG / zidovudine 300 MG) Oral Tablet

3TC 150 MG / AZT 300 MG Oral Tablet [Combivir]

lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Combivir]


Vicoprofen (HYDROcodone bitartrate 7.5 MG / ibuprofen 200 MG) Oral Tablet

HYDROcodone bitartrate 7.5 MG / ibuprofen 200 MG Oral Tablet [Vicoprofen]

Vicoprofen (hydrocodone bitartrate 7.5 MG / ibuprofen 200 MG) Oral Tablet

hydrocodone bitartrate 7.5 MG / ibuprofen 200 MG Oral Tablet [Vicoprofen]


dolasetron mesylate 20 MG/ML Injectable Solution [Anzemet]


Effexor XR 150 MG 24HR Extended Release Oral Capsule

24 HR venlafaxine 150 MG Extended Release Oral Capsule [Effexor]

Effexor XR 150 MG 24 HR Extended Release Oral Capsule

Effexor XR 150 MG (as venlafaxine hydrochloride) 24 HR Extended Release Oral Capsule

24 HR Effexor 150 MG Extended Release Oral Capsule


Effexor XR 37.5 MG 24 HR Extended Release Oral Capsule

24 HR Effexor 37.5 MG Extended Release Oral Capsule

Effexor XR 37.5 MG (as venlafaxine hydrochloride) 24 HR Extended Release Oral Capsule

Effexor XR 37.5 MG 24HR Extended Release Oral Capsule

24 HR venlafaxine 37.5 MG Extended Release Oral Capsule [Effexor]


Librax (chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG) Oral Capsule

Librax (chlordiazePOXIDE hydrochloride 5 MG / clidinium bromide 2.5 MG) Oral Capsule

chlordiazePOXIDE hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule [Librax]

chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule [Librax]


Effexor XR 75 MG 24HR Extended Release Oral Capsule

Effexor XR 75 MG (as venlafaxine hydrochloride) 24 HR Extended Release Oral Capsule

Effexor XR 75 MG 24 HR Extended Release Oral Capsule

24 HR venlafaxine 75 MG Extended Release Oral Capsule [Effexor]

24 HR Effexor 75 MG Extended Release Oral Capsule


Rogaine 5 % Topical Solution
Rogaine 50 MG/ML Topical Solution
Rogaine Men's 5 % Topical Solution

minoxidil 50 MG/ML Topical Solution [Rogaine]


ePHEDrine hydrochloride 12.5 MG / guaiFENesin 200 MG Oral Tablet [Primatene with ePHEDrine & guaiFENesin]

Primatene with ePHEDrine & guaiFENesin 12.5 MG / 200 MG Oral Tablet

Primatene (ePHEDrine hydrochloride 12.5 MG / guaiFENesin 200 MG) Oral Tablet

Primatene (ephedrine hydrochloride 12.5 MG / guaifenesin 200 MG) Oral Tablet

ephedrine hydrochloride 12.5 MG / guaifenesin 200 MG Oral Tablet [Primatene with ephedrine & guaifenesin]


capsaicin 0.33 MG/ML Topical Cream [Zostrix]


benzoyl peroxide 60 MG/ML Medicated Liquid Soap [Triaz]


metroNIDAZOLE 10 MG/ML Topical Cream [Noritate]

metronidazole 10 MG/ML Topical Cream [Noritate]


tiaGABine hydrochloride 20 MG Oral Tablet [Gabitril]

tiagabine hydrochloride 20 MG Oral Tablet [Gabitril]


10 ML rituximab 10 MG/ML Injection [Rituxan]

10 ML riTUXimab 10 MG/ML Injection [Rituxan]


NEUMEGA 5 MG Injection
Neumega 5 MG Injection


guaiFENesin 20 MG/ML Oral Solution [Robafen]

guaifenesin 20 MG/ML Oral Solution [Robafen]


Scot-Tussin 100 MG in 5 mL Oral Solution

Scot-Tussin 100 MG per 5 ML Oral Solution

guaiFENesin 20 MG/ML Oral Solution [Scot-Tussin]

guaifenesin 20 MG/ML Oral Solution [Scot-Tussin]


Siltussin SA 100 MG per 5 ML Oral Solution

Siltussin SA 100 MG in 5 mL Oral Solution

guaiFENesin 20 MG/ML Oral Solution [Siltussin]

guaifenesin 20 MG/ML Oral Solution [Siltussin]


Zomig 5 MG Oral Tablet
ZOLMitriptan 5 MG Oral Tablet [Zomig]


Plavix 75 MG (clopidogrel bisulfate 97.875 MG) Oral Tablet


PRECOSE 25 MG Oral Tablet
Precose 25 MG Oral Tablet


raloxifene hydrochloride 60 MG Oral Tablet [Evista]


Propecia 1 MG Oral Tablet
FIN5C 1 MG Oral Tablet [Propecia]


Bactroban 20 MG/ML Topical Cream
Bactroban 2 % Topical Cream
BACTROBAN 2 % Topical Cream

mupirocin 20 MG/ML Topical Cream [Bactroban]


Allegra-D 12 Hour (fexofenadine hydrochloride 60 MG / pseudoephedrine hydrochloride 120 MG) Extended Release Oral Tablet

Allegra-D 60 MG /120 MG 12HR Extended Release Oral Tablet

12 HR fexofenadine hydrochloride 60 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Allegra-D]


Floxin 0.3 % Otic Solution
Floxin 3 MG/ML Otic Solution

ofloxacin 3 MG/ML Otic Solution [Floxin]


Tobi 300 MG per 5 ML Inhalation Solution

TOBI 300 MG per 5 ML Inhalation Solution

tobramycin 60 MG/ML Inhalation Solution [Tobi]


sodium phenylbutyrate 500 MG Oral Tablet [Buphenyl]


REGRANEX 0.01 % Topical Gel
Regranex 0.01 % Topical Gel
Regranex 100 MCG per GM Topical Gel
Regranex 0.0001 MG/MG Topical Gel

becaplermin 0.0001 MG/MG Topical Gel [Regranex]


Flagyl ER 750 MG 24 HR Extended Release Oral Tablet

Flagyl ER 750 MG 24HR Extended Release Oral Tablet

24 HR Flagyl ER 750 MG Extended Release Oral Tablet

24 HR metroNIDAZOLE 750 MG Extended Release Oral Tablet [Flagyl]

24 HR metronidazole 750 MG Extended Release Oral Tablet [Flagyl]


Amerge 1 MG (naratriptan hydrochloride 1.11 MG) Oral Tablet


Amerge 2.5 MG (naratriptan hydrochloride 2.78 MG) Oral Tablet


ciprofloxacin 50 MG/ML Oral Suspension [Cipro]


ciprofloxacin 100 MG/ML Oral Suspension [Cipro]


tolterodine tartrate 1 MG Oral Tablet [Detrol]


tolterodine tartrate 2 MG Oral Tablet [Detrol]


hydroCHLOROthiazide 12.5 MG / valsartan 160 MG Oral Tablet [Diovan HCT]

Diovan HCT 160/12.5 (valsartan / HCTZ) Oral Tablet

HCTZ 12.5 MG / valsartan 160 MG Oral Tablet [Diovan HCT]

hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet [Diovan HCT]


hydroCHLOROthiazide 12.5 MG / valsartan 80 MG Oral Tablet [Diovan HCT]

HCTZ 12.5 MG / valsartan 80 MG Oral Tablet [Diovan HCT]

Diovan HCT 80/12.5 (valsartan / HCTZ) Oral Tablet

hydrochlorothiazide 12.5 MG / valsartan 80 MG Oral Tablet [Diovan HCT]


Prep-Hem (cocoa butter 85.5 % / phenylephrine 0.25 % / shark liver oil preparation 3 % ) Rectal Suppository

Prep-Hem 85.5 % / 0.25 % / 3 % Rectal Suppository

cocoa butter 0.855 MG/MG / phenylephrine 0.0025 MG/MG / shark liver oil 0.03 MG/MG Rectal Suppository [Prep-Hem]


Lomotil (atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG) Oral Tablet

atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet [Lomotil]


Lonox (atropine sulfate 0.025 MG / diphenoxylate HCl 2.5 MG) Oral Tablet

Lonox (atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG) Oral Tablet

atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet [Lonox]


pramipexole dihydrochloride 0.5 MG Oral Tablet [Mirapex]


Alrex 2 MG/ML Ophthalmic Suspension
Alrex 0.2 % Ophthalmic Suspension

loteprednol etabonate 2 MG/ML Ophthalmic Suspension [Alrex]


Lotemax 5 MG/ML Ophthalmic Suspension
Lotemax 0.5 % Ophthalmic Suspension

loteprednol etabonate 5 MG/ML Ophthalmic Suspension [Lotemax]


60 ACTUAT Flovent 0.1 MG/ACTUAT Dry Powder Inhaler

60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT Dry Powder Inhaler [Flovent]

Flovent Diskus 100 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUAT

Flovent Diskus 0.1 MG/ACTUAT Dry Powder Inhaler, 60 ACTUAT

Flovent Diskus 100 MCG/INHAL Dry Powder Inhaler, 60 Blisters


60 ACTUAT Flovent 0.25 MG/ACTUAT Dry Powder Inhaler

Flovent Diskus 250 MCG/INHAL Dry Powder Inhaler, 60 Blisters

Flovent Diskus 0.25 MG/ACTUAT Dry Powder Inhaler, 60 ACTUAT

Flovent Diskus 250 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUAT

60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT Dry Powder Inhaler [Flovent]


Nesacaine 10 MG/ML Injectable Solution
Nesacaine 1 % Injectable Solution

chloroprocaine hydrochloride 10 MG/ML Injectable Solution [Nesacaine]


Viagra 25 MG (as sildenafil citrate) Oral Tablet


Viagra 50 MG (as sildenafil citrate) Oral Tablet


Viagra 100 MG (as sildenafil citrate) Oral Tablet


Azopt 1 % Ophthalmic Suspension
Azopt 10 MG/ML Ophthalmic Suspension

brinzolamide 10 MG/ML Ophthalmic Suspension [Azopt]


Magonate Reformulated May 2022 54 MG per 5 ML Oral Solution

Magonate Reformulated May 2022 10.8 MG/ML Oral Solution

Magonate 54 MG in 5 ML Oral Solution, Reformulated May 2022

magnesium carbonate 10.8 MG/ML Oral Solution [Magonate Reformulated May 2022]


Nesacaine 2 % Injectable Solution
Nesacaine 20 MG/ML Injectable Solution

chloroprocaine hydrochloride 20 MG/ML Injectable Solution [Nesacaine]


U-Lactin (lactic acid 2 % / urea 10 % ) Topical Lotion

lactic acid 20 MG/ML / urea 100 MG/ML Topical Lotion [U-Lactin]


Cosopt (dorzolamide 20 MG / timolol 5 MG) per ML Ophthalmic Solution

dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Cosopt]


hydroxyurea 200 MG Oral Capsule [Droxia]


hydroxyurea 300 MG Oral Capsule [Droxia]


hydroxyurea 400 MG Oral Capsule [Droxia]


PARoxetine hydrochloride 2 MG/ML Oral Suspension [Paxil]

paroxetine hydrochloride 2 MG/ML Oral Suspension [Paxil]


capecitabine 150 MG Oral Tablet [Xeloda]


capecitabine 500 MG Oral Tablet [Xeloda]


omeprazole 40 MG Delayed Release Oral Capsule [PriLOSEC]

omeprazole 40 MG Delayed Release Oral Capsule [Prilosec]

PriLOSEC 40 MG Delayed Release Oral Capsule

Prilosec 40 MG Delayed Release Oral Capsule


Nesacaine 3 % in 20 ML Injection
Nesacaine 3 % per 20 ML Injection
20 ML Nesacaine 30 MG/ML Injection

20 ML chloroprocaine hydrochloride 30 MG/ML Injection [Nesacaine]


Zemplar 10 MCG per 2 ML Injectable Solution

Zemplar 5 MCG per 1 ML Injectable Solution

paricalcitol 0.005 MG/ML Injectable Solution [Zemplar]


2 ML Cogentin 1 MG/ML Injection
Cogentin 2 MG in 2 ML Injection
Cogentin 2 MG per 2 ML Injection

2 ML benztropine mesylate 1 MG/ML Injection [Cogentin]


dantrolene sodium 50 MG Oral Capsule [Dantrium]


Ciloxan 0.003 MG/MG Ophthalmic Ointment
Ciloxan 0.3 % Ophthalmic Ointment

ciprofloxacin 0.003 MG/MG Ophthalmic Ointment [Ciloxan]


Cipro HC (ciprofloxacin 0.2 % / hydrocortisone 1 % ) Otic Suspension

ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension [Cipro HC]


Maxalt-MLT 5 MG Disintegrating Oral Tablet

rizatriptan 5 MG Disintegrating Oral Tablet [Maxalt]


rizatriptan 10 MG Disintegrating Oral Tablet [Maxalt]

Maxalt-MLT 10 MG Disintegrating Oral Tablet


Sucraid 8500 UNT per 1 ML Oral Solution
Sucraid 8500 UNT in 1 mL Oral Solution

sacrosidase 8500 UNT/ML Oral Solution [Sucraid]


Celexa 20 MG Oral Tablet
CeleXA 20 MG Oral Tablet
citalopram 20 MG Oral Tablet [Celexa]


CeleXA 40 MG Oral Tablet
citalopram 40 MG Oral Tablet [CeleXA]
Celexa 40 MG Oral Tablet


Aquaphilic with Urea 10 % Topical Ointment

urea 0.1 MG/MG Topical Ointment [Aquaphilic with Urea]


thalidomide 50 MG Oral Capsule [Thalomid]


Remicade 100 MG Injection
Remicade 100 MG per 10 ML Injection
inFLIXimab 100 MG Injection [Remicade]


candesartan cilexetil 8 MG Oral Tablet [Atacand]


candesartan cilexetil 16 MG Oral Tablet [Atacand]


candesartan cilexetil 32 MG Oral Tablet [Atacand]


resorcinol 30 MG/ML Topical Lotion [R A Acne]


SUSTIVA 200 MG Oral Capsule
Sustiva 200 MG Oral Capsule


SUSTIVA 50 MG Oral Capsule
Sustiva 50 MG Oral Capsule


X-Seb T Plus (crude coal tar 2 % (coal tar solution 10 % )) Medicated Shampoo

coal tar 20 MG/ML Medicated Shampoo [X-Seb T Plus]


Cellcept 500 MG Injection
CellCept 500 MG Injection

mycophenolate mofetil 500 MG Injection [Cellcept]


Leukine 500 MCG/ML Injectable Solution
Leukine 0.5 MG/ML Injectable Solution

sargramostim 0.5 MG/ML Injectable Solution [Leukine]


Aloe Vesta Clear Antifungal 2 % Topical Ointment

ALOE VESTA Antifungal 2 % Topical Ointment

Aloe Vesta Antifungal 0.02 MG/MG Topical Ointment

miconazole nitrate 0.02 MG/MG Topical Ointment [Aloe Vesta Antifungal]


Opcon A (naphazoline hydrochloride 0.027 % / pheniramine maleate 0.315 % ) Ophthalmic Solution

Opcon-A 0.02675 % / 0.315 % Ophthalmic Solution

Opcon-A (naphazoline hydrochloride 0.02675 % / pheniramine maleate 0.315 % ) Ophthalmic Solution

naphazoline hydrochloride 0.27 MG/ML / pheniramine maleate 3.15 MG/ML Ophthalmic Solution [Opcon-A]


DERMATOP 0.1 % Topical Ointment
Dermatop 0.001 MG/MG Topical Ointment
Dermatop 0.1 % Topical Ointment

prednicarbate 0.001 MG/MG Topical Ointment [Dermatop]


Viramune 50 MG per 5 ML Oral Suspension
Viramune 10 MG/ML Oral Suspension
Viramune 50 MG in 5 mL Oral Suspension

nevirapine 10 MG/ML Oral Suspension [Viramune]


Claritin RediTabs 10 MG 24HR Disintegrating Oral Tablet

Claritin 24HR RediTabs 10 MG Disintegrating Oral Tablet

Claritin 10 MG Disintegrating Oral Tablet

loratadine 10 MG Disintegrating Oral Tablet [Claritin]


telmisartan 40 MG Oral Tablet [Micardis]


telmisartan 80 MG Oral Tablet [Micardis]


Diuril 250 MG in 5 mL Oral Suspension
Diuril 50 MG/ML Oral Suspension
Diuril 250 MG per 5 ML Oral Suspension

chlorothiazide 50 MG/ML Oral Suspension [Diuril]


insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [HumuLIN]

insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]


insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Novolin]

Relion Novolin 70/30 Injectable Suspension

insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [NovoLIN]

Relion NovoLIN 70/30 Injectable Suspension


Topamax 25 MG Oral Capsule
Topamax 25 MG Oral Sprinkle Capsule


Topamax 15 MG Oral Sprinkle Capsule
Topamax 15 MG Oral Capsule


HCTZ 25 MG / Losartan Pot 100 MG Oral Tablet [Hyzaar]

HCTZ 25 MG / Losartan K+ 100 MG Oral Tablet [Hyzaar]

Hyzaar 100/25 (hydroCHLOROthiazide 25 MG / losartan potassium 100 MG) Oral Tablet

hydroCHLOROthiazide 25 MG / losartan potassium 100 MG Oral Tablet [Hyzaar]

Hyzaar 100/25 (hydrochlorothiazide 25 MG / losartan potassium 100 MG) Oral Tablet

hydrochlorothiazide 25 MG / losartan potassium 100 MG Oral Tablet [Hyzaar]


Diuril Sodium 500 MG Injection
Diuril 500 MG Injection
Sodium Diuril 0.5 GM Injection

chlorothiazide 500 MG Injection [Diuril]


metFORMIN hydrochloride 1000 MG Oral Tablet [Glucophage]

metformin hydrochloride 1000 MG Oral Tablet [Glucophage]


Ziagen 20 MG/ML Oral Solution
ZIAGEN 20 MG in 1 mL Oral Solution
Ziagen 20 MG per 1 ML Oral Solution

abacavir 20 MG/ML Oral Solution [Ziagen]


24 HR oxybutynin chloride 5 MG Extended Release Oral Tablet [Ditropan]

Ditropan XL 5 MG 24 HR Extended Release Oral Tablet

Ditropan XL 5 MG 24HR Extended Release Oral Tablet


24 HR Ditropan 10 MG Extended Release Oral Tablet

Ditropan 10 MG 24 HR Extended Release Oral Tablet

Ditropan XL 10 MG 24HR Extended Release Oral Tablet

24 HR oxybutynin chloride 10 MG Extended Release Oral Tablet [Ditropan]


celecoxib 100 MG Oral Capsule [Celebrex]

celecoxib 100 MG Oral Capsule [CeleBREX]


celecoxib 200 MG Oral Capsule [CeleBREX]

celecoxib 200 MG Oral Capsule [Celebrex]


Survanta 25 MG/ML Intratracheal Suspension

SURVANTA 25 MG/ML Intratracheal Suspension

beractant 25 MG/ML Intratracheal Suspension [Survanta]


1 ML EPO 40000 UNT/ML Injection [Procrit]

1 ML ERYTHROPOIETIN 40000 UNT/ML Injection [Procrit]

1 ML epoetin alfa 40000 UNT/ML Injection [Procrit]


Enlon-Plus (atropine sulfate 0.14 MG / edrophonium chloride 10 MG) per 1 ML Injection

Enlon-Plus 10 MG/ML / 0.14 MG/ML in 5 ML Injection

5 ML atropine sulfate 0.14 MG/ML / edrophonium chloride 10 MG/ML Injection [Enlon-Plus]


Zestril 30 MG Oral Tablet, Once-Daily
Zestril 30 MG Oral Tablet


lamiVUDine 100 MG Oral Tablet [Epivir HBV]

lamivudine 100 MG Oral Tablet [Epivir HBV]


lamiVUDine 5 MG/ML Oral Solution [Epivir HBV]

lamivudine 5 MG/ML Oral Solution [Epivir HBV]


Peroxyl 1.5 % Mucous Membrane Topical Solution

Peroxyl 15 MG/ML Mucous Membrane Topical Solution

hydrogen peroxide 15 MG/ML Mucous Membrane Topical Solution [Peroxyl]


Peroxyl 1.5 % Oral Gel
Peroxyl 0.015 MG/MG Oral Gel

hydrogen peroxide 0.015 MG/MG Oral Gel [Peroxyl]


Panretin 0.1 % Topical Gel
Panretin 0.001 MG/MG Topical Gel

alitretinoin 0.001 MG/MG Topical Gel [Panretin]


Del-Beta 0.5 MG/ML (betamethasone dipropionate 0.64 MG/ML) Topical Cream

betamethasone 0.5 MG/ML Topical Cream [Del-Beta]


acetohydroxamic acid 250 MG Oral Tablet [Lithostat]


Miacalcin 200 UNT/ML Injectable Solution

salmon calcitonin 200 UNT/ML Injectable Solution [Miacalcin]


Augmented Diprolene 0.05 % Topical Cream

Diprolene 0.5 MG/ML (betamethasone dipropionate 0.64 MG/ML) Augmented Topical Cream

Diprolene 0.05 % Augmented Topical Cream

Augmented betamethasone 0.5 MG/ML Topical Cream [Diprolene]


Diprolene 0.5 MG/ML (betamethasone dipropionate 0.64 MG/ML) Augmented Topical Lotion

Diprolene 0.05 % Augmented Topical Lotion

Augmented Diprolene 0.5 MG/ML Topical Lotion

Augmented betamethasone 0.5 MG/ML Topical Lotion [Diprolene]


aztreonam 2000 MG Injection [Azactam]
Azactam 2000 MG Injection


Augmented Diprolene 0.0005 MG/MG Topical Ointment

Diprolene 0.0005 MG/MG Augmented Topical Ointment

Diprolene 0.5 MG/ML (betamethasone dipropionate 0.64 MG/ML) Augmented Topical Ointment

Diprolene (betamethasone dipropionate) 0.05 % Augmented Topical Ointment

Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene]


Miochol 20 MG per 2 ML (1 % ) Intraocular Solution

Miochol-E 20 MG in 2 mL Ophthalmic Solution

acetylcholine chloride 10 MG/ML Ophthalmic Solution [Miochol]


Celestone Soluspan 6 MG/ML Injectable Suspension

Celestone Soluspan (betamethasone (as betamethasone sodium phosphate) 3 MG / betamethasone acetate 3 MG) per ML Injectable Suspension

betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension [Celestone Soluspan]


Polycin 500 UNT/GM / 10,000 UNT/GM Ophthalmic Ointment

Polycin-B (bacitracin 500 UNT/GM / polymyxin B 10,000 UNT/GM) Ophthalmic Ointment

bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Polycin]


CARBOplatin 10 MG/ML Injectable Solution [Paraplatin]

Paraplatin 150 MG per 15 ML Injectable Solution

Paraplatin 50 MG per 5 ML Injectable Solution

carboplatin 10 MG/ML Injectable Solution [Paraplatin]


Polysporin (bacitracin 500 UNT / polymyxin B 10,000 UNT) per GM Topical Ointment

Polysporin 500 UNT / 10,000 UNT per GM Topical Ointment

Polysporin (bacitracin 0.5 UNT / polymyxin B 10 UNT) per MG Topical Ointment

bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment [Polysporin]


Semprex-D (acrivastine 8 MG / pseudoephedrine hydrochloride 60 MG) Oral Capsule

acrivastine 8 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule [Semprex-D]


Hemabate 250 MCG in 1 ML Injection
Hemabate 250 MCG per 1 ML Injection
1 ML Hemabate 0.25 MG/ML Injection

1 ML carboprost 0.25 MG/ML Injection [Hemabate]


Lotrisone (betamethasone 0.5 MG (betamethasone dipropionate 0.643 MG) / clotrimazole 10 MG) per ML Topical Cream

Lotrisone (betamethasone 0.05 % / clotrimazole 1 % ) Topical Cream

betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Cream [Lotrisone]


acycycloguanosine 200 MG Oral Capsule [Zovirax]


carisoprodol 350 MG Oral Tablet [Vanadom]


acycycloguanosine 800 MG Oral Tablet [Zovirax]


Ocupress 1 % Ophthalmic Solution
Ocupress 10 MG/ML Ophthalmic Solution

carteolol hydrochloride 10 MG/ML Ophthalmic Solution [Ocupress]


Lioresal 10 MG per 20 ML (500 MCG/ML) Injection

LIORESAL INTRATHECAL 10 MG in 20 ML (500 MCG/ML) Injection

20 ML baclofen 0.5 MG/ML Injection [Lioresal]


5 ML baclofen 2 MG/ML Injection [Lioresal]

LIORESAL INTRATHECAL 10 MG in 5 ML (2,000 MCG/ML) Injection

Lioresal 10 MG per 5 ML (2,000 MCG/ML) Injection


Betoptic S 2.5 MG/ML (betaxolol hydrochloride 2.8 MG/ML) Ophthalmic Suspension

betaxolol 2.5 MG/ML Ophthalmic Suspension [Betoptic S]


Tice BCG 50 MG for Intravesical Suspension

BCG, live, Tice strain 50 MG/ML Topical Suspension [Tice BCG]


bethanechol chloride 5 MG Oral Tablet [Urecholine]


bethanechol chloride 10 MG Oral Tablet [Urecholine]


bethanechol chloride 25 MG Oral Tablet [Urecholine]


bethanechol chloride 50 MG Oral Tablet [Urecholine]


Donnatal (atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / PHENobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG) Oral Tablet

atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / PHENobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet [Donnatal]

atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet [Donnatal]

Donnatal 0.0194 MG / 0.1037 MG / 16.2 MG / 0.0065 MG Oral Tablet

Donnatal (atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG) Oral Tablet


5-5-fluorouracil 50 MG/ML Injectable Solution [Adrucil]

5-FU 50 MG/ML Injectable Solution [Adrucil]


atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / PHENobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [D-Tal]

D-Tal (atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / PHENobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML) Oral Solution

D-Tal (PHENobarbital 16.2 MG / hyoscyamine sulfate 0.1037 MG / atropine sulfate 0.0194 MG / scopolamine hydrobromide 0.0065 MG per 5 ML) Oral Solution

D-Tal (atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML) Oral Solution

D-Tal 16.2 MG / 0.1037 MG / 0.0194 MG / 0.0065 MG in 5 mL Oral Solution

D-Tal (phenobarbital 16.2 MG / hyoscyamine sulfate 0.1037 MG / atropine sulfate 0.0194 MG / scopolamine hydrobromide 0.0065 MG per 5 ML) Oral Solution

atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [D-Tal]


atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / PHENobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Donnatal]

Donnatal (atropine sulfate 0.00388 MG / hyoscyamine sulfate 0.0207 MG / PHENobarbital 3.24 MG / scopolamine hydrobromide 0.0013 MG) per ML Oral Solution

atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Donnatal]

Donnatal 16.2 MG / 0.1037 MG / 0.0194 MG / 0.0065 MG in 5 mL Oral Solution

Donnatal (atropine sulfate 0.0388 MG / hyoscyamine sulfate 0.2074 MG / PHENobarbital 32.4 MG / scopolamine hydrobromide 0.013 MG) per 10 ML Oral Solution

Donnatal (atropine sulfate 0.0388 MG / hyoscyamine sulfate 0.2074 MG / phenobarbital 32.4 MG / scopolamine hydrobromide 0.013 MG) per 10 ML Oral Solution

Donnatal (atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG) per 5 ML Oral Solution

Donnatal (atropine sulfate 0.00388 MG / hyoscyamine sulfate 0.0207 MG / phenobarbital 3.24 MG / scopolamine hydrobromide 0.0013 MG) per ML Oral Solution

Donnatal (atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / PHENobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG) per 5 ML Oral Solution


Aclovate 0.5 MG/ML Topical Cream
Aclovate 0.05 % Topical Cream

alclometasone dipropionate 0.5 MG/ML Topical Cream [Aclovate]


bisoprolol fumarate 5 MG Oral Tablet [Zebeta]


Bisoprolol Fumarate 2.5 MG / HCTZ 6.25 MG Oral Tablet [Ziac]

Ziac 2.5/6.25 (bisoprolol fumarate / HCTZ) Oral Tablet

bisoprolol fumarate 2.5 MG / hydroCHLOROthiazide 6.25 MG Oral Tablet [Ziac]

bisoprolol fumarate 2.5 MG / hydrochlorothiazide 6.25 MG Oral Tablet [Ziac]


Ziac 5/6.25 (bisoprolol fumarate / HCTZ) Oral Tablet

Bisoprolol Fumarate 5 MG / HCTZ 6.25 MG Oral Tablet [Ziac]

bisoprolol fumarate 5 MG / hydroCHLOROthiazide 6.25 MG Oral Tablet [Ziac]

bisoprolol fumarate 5 MG / hydrochlorothiazide 6.25 MG Oral Tablet [Ziac]


bisoprolol fumarate 10 MG / hydroCHLOROthiazide 6.25 MG Oral Tablet [Ziac]

Bisoprolol Fumarate 10 MG / HCTZ 6.25 MG Oral Tablet [Ziac]

Ziac 10/6.25 (bisoprolol fumarate / HCTZ) Oral Tablet

bisoprolol fumarate 10 MG / hydrochlorothiazide 6.25 MG Oral Tablet [Ziac]


ZYLOPRIM 100 MG Oral Tablet
Zyloprim 100 MG Oral Tablet

allopurinol 100 MG Oral Tablet [Zyloprim]


ZYLOPRIM 300 MG Oral Tablet
Zyloprim 300 MG Oral Tablet

allopurinol 300 MG Oral Tablet [Zyloprim]


onabotulinumtoxinA 100 UNT Injection [Botox]


alprazolam 1 MG Oral Tablet [Xanax]
ALPRAZolam 1 MG Oral Tablet [Xanax]


ALPRAZolam 2 MG Oral Tablet [Xanax]
Xanax 2 MG Oral Tablet


cefoTEtan 2000 MG Injection [Cefotan]
Cefotan 2 GM Injection


cefoxitin 1000 MG Injection [Mefoxin]
cefOXitin 1000 MG Injection [Mefoxin]


cefoxitin 2000 MG Injection [Mefoxin]
Mefoxin 2 GM Injection


Thalitone 15 MG Oral Tablet
THALITONE 15 MG Oral Tablet

chlorthalidone 15 MG Oral Tablet [Thalitone]


THALITONE 25 MG Oral Tablet
Thalitone 25 MG Oral Tablet

chlorthalidone 25 MG Oral Tablet [Thalitone]


Clorpres (chlorthalidone 15 MG / clonidine hydrochloride 0.1 MG) Oral Tablet

Clorpres (chlorthalidone 15 MG / cloNIDine hydrochloride 0.1 MG) Oral Tablet

chlorthalidone 15 MG / cloNIDine hydrochloride 0.1 MG Oral Tablet [Clorpres]

chlorthalidone 15 MG / clonidine hydrochloride 0.1 MG Oral Tablet [Clorpres]


chlorthalidone 15 MG / cloNIDine hydrochloride 0.2 MG Oral Tablet [Clorpres]

Clorpres (chlorthalidone 15 MG / clonidine hydrochloride 0.2 MG) Oral Tablet

Clorpres (chlorthalidone 15 MG / cloNIDine hydrochloride 0.2 MG) Oral Tablet

chlorthalidone 15 MG / clonidine hydrochloride 0.2 MG Oral Tablet [Clorpres]


chlorthalidone 15 MG / cloNIDine hydrochloride 0.3 MG Oral Tablet [Clorpres]

Clorpres (chlorthalidone 15 MG / clonidine hydrochloride 0.3 MG) Oral Tablet

Clorpres (chlorthalidone 15 MG / cloNIDine hydrochloride 0.3 MG) Oral Tablet

chlorthalidone 15 MG / clonidine hydrochloride 0.3 MG Oral Tablet [Clorpres]


Dritho-creme 0.1 % Topical Cream
Drithocreme 0.1 % Topical Cream
Drithocreme 1 MG/ML Topical Cream

anthralin 1 MG/ML Topical Cream [Drithocreme]


chlorzoxazone 500 MG Oral Tablet [Parafon Forte DSC]


acetaminophen / brompheniramine / phenylpropanolamine


A combination preparation of acetaminophen, butalbital, and caffeine. Acetaminophen exerts antipyretic and analgesic activities by inhibiting prostaglandin synthesis. Butalbital, a barbiturate with an intermediate duration of action, depresses the central nervous system and exerts sedative activity. Caffeine is a central nervous system stimulant and causes constriction of dilated cerebral blood vessels. This combination is used for the relief and treatment of migraine and tension headaches.


A combination preparation containing pyrilamine, caffeine and acetaminophen. Pyrilamine is an ethylenediamine antihistamine that blocks H1 receptors and exerts local anesthetic, sedative and mild analgesic activities. Caffeine is a central nervous system stimulant. Acetaminophen possesses analgesic and antipyretic effects. This preparation is used for the relief of premenstrual and menstrual symptoms.


acetaminophen / dichloralphenazone / isometheptene

A combination preparation containing isometheptane, dichloralphenazone and acetaminophen with analgesic activity. Isometheptene is an indirect-acting sympathomimetic agent with vasoconstricting activity, thereby reducing the pulsation in cerebral arteries by constricting dilated cerebral blood vessels. Dichloralphenazone, a complex of chloral hydrate, which possesses hypnotic and sedative activity, and antipyrine, a pyrazolone analgesic and an antipyretic. Acetaminophen inhibits prostaglandin synthesis, thereby exerting analgesic activity. This preparation is used for the relief of migraine and tension headaches.


A combination preparation containing pyrilamine, pamabron and acetaminophen. Pyrilamine is an ethylenediamine antihistamine that blocks H1 receptors and exerts local anesthetic, sedative and mild analgesic activity. Pamabrom, a xanthine derivate, is a mild diuretic that helps the body to excrete excess fluid. Acetaminophen possesses analgesic and antipyretic effects. This preparation is used for the relief of premenstrual and menstrual symptoms.


aspirin / butalbital / caffeine / codeine


A synthetic p-aminophenol derivative and diphenhydramine combination with anti-inflammatory, analgesic, and anti-allergic properties. Acetaminophen Diphenhydramine is used to treat symptoms of allergies and hay fever. The active principal metabolite of phenacetin, acetaminophen appears to inhibit prostaglandin biosynthesis in the central nervous system and less in peripheral tissues. Diphenhydramine blocks histamine effects, preventing sneezing and itchy, watery eyes, as well as nasal and other allergy and hay fever symptoms. (NCI04)


A combination preparation of the analgesic acetaminophen and the semisynthetic opioid agonist hydrocodone with analgesic and antitussive activities. Acetaminophen exerts its analgesic activity by inhibiting prostaglandin synthesis while hydrocodone exerts its analgesic activity by binding to the mu-receptors in the central nervous system (CNS), thereby mimicking the effects of endogenous opioids.


A combination preparation of the analgesic and antipyretic acetaminophen and the semisynthetic opioid agonist oxycodone with analgesic and antitussive properties. Acetaminophen exerts its analgesic activity by inhibiting prostaglandin synthesis, while oxycodone exerts its analgesic activity by binding to the mu-receptors in the central nervous system (CNS), thereby mimicking the effects of endogenous opioids.


A combined pharmaceutical preparation of Ipratropium Bromide and Albuterol Sulfate that is used to treat the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.


alginic acid / aluminum hydroxide / magnesium carbonate


antazoline / naphazoline Ophthalmic Product


antipyrine / benzocaine / phenylephrine Otic Product


bacitracin / polymyxin B Ophthalmic Product


bacitracin / hydrocortisone / neomycin / polymyxin B Ophthalmic Product


bacitracin / hydrocortisone / neomycin / polymyxin B Topical Product


bacitracin / lidocaine / neomycin / polymyxin B Topical Product


bacitracin / neomycin / polymyxin B Ophthalmic Product


castor oil / Peruvian balsam / trypsin Topical Product


A combination preparation of the synthetic angiotensin-converting enzyme (ACE) inhibitor prodrug benazepril and the thiazide diuretic hydrochlorothiazide, with antihypertensive activity. Benazepril is de-esterified by the liver into its active form benazeprilat, which competitively inhibits ACE. ACE inhibition prevents the formation of angiotensin II, and blocks angiotensin II-mediated activities, including vasoconstriction and stimulation of synthesis and secretion of aldosterone, which leads to an increase in sodium excretion and increases water outflow. Hydrochlorothiazide inhibits electrolyte reabsorption via binding to the Na-Cl cotransporter on the renal distal tubules, thereby increasing excretion of sodium, potassium, chloride, bicarbonate and water. Together, these agents lead to a reduction in blood pressure.


benoxinate / fluorescein Ophthalmic Product


brompheniramine / codeine / phenylpropanolamine


A calcium salt of acetic acid. Calcium is a mineral essential for many cellular functions including nerve impulse transmission, muscle contraction, cardiac function, bone formation, and capillary and cell membrane permeability. Calcium acetate is administered orally to prevent or treat calcium deficiency and to treat hyperphosphatemia due to its phosphate-binding properties.


calcium glycerophosphate / calcium lactate


A synthetic, benzimidazole-derived angiotensin II receptor antagonist prodrug with antihypertensive activity. Candesartan selectively competes with angiotensin II for the binding of the angiotensin II receptor subtype 1 (AT1) in vascular smooth muscle, blocking angiotensin II-mediated vasoconstriction and inducing vasodilatation. In addition, antagonism of AT1 in the adrenal gland inhibits angiotensin II-stimulated aldosterone synthesis and secretion by the adrenal cortex; sodium and water excretion increase, followed by a reduction in plasma volume and blood pressure.


A combination of laxatives, Casanthranol Docusate is used in constipation and various medical conditions. Casanthranol is a concentrated mixture of anthranol glycosides from cascara sagrada (dried bark of Rhamnus p.) and a stimulant laxative that encourages bowel movements by acting on the intestinal wall to increase muscle contractions. A surface-active emollient, stool softener Docusate helps liquids to mix into dry stool, allowing patients to have a bowel movement without straining. (NCI04)


chloramphenicol / hydrocortisone / polymyxin B Ophthalmic Product


chloroxylenol / hydrocortisone / pramoxine Otic Product


chlorpheniramine / ePHEDrine / guaiFENesin

chlorpheniramine / ephedrine / guaifenesin


chlorpheniramine / guaiFENesin / phenylephrine

chlorpheniramine / guaifenesin / phenylephrine


chlorpheniramine / guaiFENesin / pseudoephedrine

chlorpheniramine / guaifenesin / pseudoephedrine


chlorpheniramine / HYDROcodone / phenylephrine

chlorpheniramine / hydrocodone / phenylephrine


chlorpheniramine / methscopolamine / phenylpropanolamine


chlorpheniramine / phenylephrine / pyrilamine


A combination preparation containing guaifenesin and the opioid agonist codeine with expectorant and antitussive activities, respectively. Guaifenesin works by drawing water into respiratory tracts, by which reducing adhesiveness and surface tension of mucus as well as increasing hydration of mucus, thereby reducing the viscosity of mucus and making cough more productive. Codeine, a naturally occurring phenanthrene alkaloid and opioid agonist mimics the actions of opioids by binding to the opioid receptors at many sites within the central nervous system (CNS), thereby also suppressing the cough reflex by activating receptors in the cough center.


codeine / guaiFENesin / phenylpropanolamine

codeine / guaifenesin / phenylpropanolamine


codeine / pseudoephedrine / triprolidine


A combination of probenecid and colchicine with antihyperuricemic activity. Probenecid, a benzoic acid derivative, competitively inhibits the reabsorption of urate at the proximal tubule in the kidney, thereby increasing urinary excretion of uric acid and lowering serum urate concentrations. This prevents urate deposition and promotes resolution of existing urate deposits. Colchicine is a natural alkaloid with anti-gout and anti-inflammatory properties. Colchicine binds to tubulin, thereby interfering with the polymerization of tubulin, interrupting microtubule dynamics, and disrupting mitosis leading to an inhibition of leukocyte migration and reduction of the inflammatory response to deposited urate crystals. This agent also interrupts monosodium urate crystal deposition in joint tissues, thereby preventing the resultant inflammatory response.


colistin / hydrocortisone / neomycin / thonzonium Otic Product


A cytotoxic recombinant protein consisting of interleukin-2 (IL-2) protein sequences fused to diphtheria toxin. The IL-2 protein sequence moiety of denileukin difitox directs the cytocidal action of diphtheria toxin to cells that express IL-2 receptors. After the toxin moiety is internalized into target IL-2 receptor-expressing cells, its catalytic domain catalyzes the transfer of the ADP-ribose moiety of NAD to a posttranslationally modified histidine residue of elongation factor 2 (EF-2), called diphthamine. This covalent modification inactivates EF-2 and disrupts polypeptide chain elongation, resulting in cell death. (NCI04)


dexamethasone / neomycin Ophthalmic Product


dexamethasone / neomycin / polymyxin B Ophthalmic Product


A combination preparation containing guaifenesin and the opioid agonist dextrometorphan with expectorant and antitussive activities, respectively. Guaifenesin works by drawing water into respiratory tracts, by which reducing adhesiveness and surface tension of mucus as well as increasing hydration of mucus, thereby reducing the viscosity of mucus and making cough more productive. Dextrometorphan, a synthetic, methylated dextrorotary analogue of levorphanol, exhibits antitussive activity by activating opioid receptors in the cough center in the central nervous system, thereby raising the threshold for coughing.


dextromethorphan / guaiFENesin / phenylephrine

dextromethorphan / guaifenesin / phenylephrine


dextromethorphan / guaiFENesin / pseudoephedrine

dextromethorphan / guaifenesin / pseudoephedrine


dextromethorphan / phenylephrine / pyrilamine


ePHEDrine / PHENobarbital / theophylline

ephedrine / phenobarbital / theophylline


A pharmaceutical preparation containing a mixture of esterified estrogens derived from estrogen sulfates, principally from ESTRONE sulfate. Esterified estrogen content should be 75-85% of the estrone sulfate and 6-15% of the EQUILIN sulfate.


A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.


A combination of two steroid sex hormones, an estrogen and a progestin, used for contraceptive purposes. Estradiol, the endogenous counterpart of ethinyl estradiol (EE), is the principal, most potent estrogen hormone produced by the ovaries and is vital to the maintenance of fertility and secondary sexual characteristics in females. Levonorgestrel is a synthetic progestogen. This drug combination prevents or delays ovulation and causes a variety of hormonal changes. Ethinyl estradiol inhibits the release of follicle stimulating hormone (FSH), thus suppressing the development of ovarian follicle; levonorgestrel inhibits the release of luteinizing hormone (LH), thus preventing ovulation. This combination of agents alters the endometrium in such a way as to discourage implantation. (NCI04)


An oral preparation combination containing the semisynthetic estrogen ethinyl estradiol and the synthetic progestagen norgestimate with contraceptive activity. Ethinyl estradiol and norgestimate act by negative feed back mechanism at pituitary gland suppressing the release of gonadotropin hormones follicle stimulating hormone (FSH) and luteinizing hormone (LH). This combination inhibits ovulation and promotes the thickening of the cervical mucus and the endometrium. The combination of ethinyl estradiol and norgestimate may also be used in the treatment of acne.


fluorescein / proparacaine Ophthalmic Product


synthetic polypeptide consisting of alanine, glutamic acid, lysine, and tyrosine; simulates myelin basic protein and is used experimentally in the treatment of relapsing and remitting multiple sclerosis.


gramicidin / neomycin / polymyxin B Ophthalmic Product


A combination preparation containing guaifenesin and the indirect-acting sympathicomimetic agent pseudoephedrine with expectorant and decongestant activities, respectively. Guaifenesin works by drawing water into respiratory tracts, by which reducing adhesiveness and surface tension of mucus as well as increasing hydration of mucus, thereby reducing the viscosity of mucus and making cough more productive. Pseudoephedrine displaces norepinephrine from storage vesicles in presynaptic neurons, thereby releasing norepinephrine into the neuronal synapses where it stimulates primarily alpha-adrenergic receptors in the nasal mucosa, thereby producing vasoconstriction, reduces swelling of nasal mucous membranes and decreasing nasal and sinus congestion.


guaiFENesin / HYDROcodone / phenylephrine

guaifenesin / hydrocodone / phenylephrine


guaiFENesin / HYDROcodone / pseudoephedrine

guaifenesin / hydrocodone / pseudoephedrine


hydrALAZINE / hydroCHLOROthiazide / reserpine

hydralazine / hydrochlorothiazide / reserpine


A combination preparation of a synthetic angiotensin II antagonist and a diuretic thiazide, with antihypertensive activity. Losartan, and its metabolite, selectively and competitively block the binding of angiotensin II to the angiotensin II (AT1) receptor. As a result, angiotensin II-AT1 mediated physiological effects such as vasoconstriction and stimulation of aldosterone synthesis and secretion, which regulates extracellular sodium concentration, are blocked. Hydrochlorothiazide inhibits electrolytes reabsorption via binding to Na-Cl cotransporter on the renal distal tubular, thereby increasing excretion of sodium, potassium, chloride, bicarbonate and water. Both agents lead to a reduction in blood pressure.


HYDROcodone / phenylephrine / pyrilamine

hydrocodone / phenylephrine / pyrilamine


hydrocortisone / oxytetracycline Ophthalmic Product


hydrocortisone / polymyxin B Otic Product


hydrocortisone / neomycin / polymyxin B Ophthalmic Product


hydrocortisone / neomycin / polymyxin B Otic Product


A combination of two synthetic nucleoside analogues with synergistic antiviral properties. Lamivudine is phosphorylated intracellularly to its active 5'-triphosphate metabolite, lamivudine triphosphate (L-TP); zidovudine is phosphorylated to its active 5'-triphosphate metabolite, zidovudine triphosphate (ZDV-TP). These active metabolites inhibit human immunodeficiency virus (HIV) viral reverse transcriptase (RT) by incorporating into viral DNA and terminating viral DNA chain elongation. (NCI04)


An oral combination preparation containing the antihistamine loratidine and the indirect-acting sympathicomimetic agent pseudoephedrine, with anti-allergic and decongestant activities. Loratadine, a piperidine, blocks the H1-receptor thereby preventing the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilatation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. Pseudoephedrine displaces norepinephrine from storage vesicles in presynaptic neurons, thereby releasing norepinephrine into the neuronal synapses where it stimulates primarily alpha-adrenergic receptors in the nasal mucosa, thereby producing vasoconstriction, reduces swelling of nasal tissues and decreasing nasal and sinus congestion.


naphazoline / phenylephrine / pyrilamine Nasal Product


oxytetracycline / polymyxin B Ophthalmic Product


pheniramine / phenyltoloxamine / pyrilamine


phenylephrine / pyrilamine Nasal Product


phenylephrine / scopolamine Ophthalmic Product


polymyxin B / trimethoprim Ophthalmic Product


potassium bicarbonate / sodium bicarbonate


A non-absorbable polymeric amine and phosphate binding agent that can be used to prevent hyperphosphatemia. Upon oral administration, the amine groups in sevelamer become protonated in the intestines and bind to the dietary phosphate groups in the gastrointestinal (GI) tract, thereby preventing the absorption of phosphate and controlling phosphate plasma levels. In addition, sevelamer, as a phosphate binder, can be used to prevent the absorption of the radionuclide phosphorus P 32 (P-32).


The sodium salt of phenylbutyrate, a derivative of the short-chain fatty acid butyrate, with potential antineoplastic activity. Phenylbutyrate reversibly inhibits class I and II histone deacetylases (HDACs), which may result in a global increase in gene expression, decreased cellular proliferation, increased cell differentiation, and the induction of apoptosis in susceptible tumor cell populations.


brand name of a medication that is used to treat vaginal yeast infections


An organic salt of ammonium (lactic acid neutralized with ammonium hydroxide), topical moisturizing Ammonium Lactate can be applied as a humectant in ichthyosis vulgaris and xerosis. Available as cream or lotion, this agent moisturizes the skin and breaks up the scales. (NCI04)


aspirin / oxyCODONE hydrochloride / oxyCODONE terephthalate

aspirin / oxycodone hydrochloride / oxycodone terephthalate


A nonsteroidal anti-inflammatory drug (NSAID) belonging to the salicylate family. Choline magnesium trisalicylate inhibits inflammation-related prostaglandin synthesis. This agent's analgesic effect is mediated through peripheral and central pathways, resulting in a decrease in pain perception; its antipyretic effect is mediated via the hypothalamic heat regulation center. (NCI04)


glucose / potassium chloride / sodium chloride


brand name of a high blood pressure medication


brand name of a drug that is used to treat rheumatism


Genac brand of pseudoephedrine/triprolidine


The hydrochloride salt of methadone, a synthetic opioid with analgesic activity. Similar to morphine and other morphine-like agents, methadone mimics the actions of endogenous peptides at CNS opioid receptors, primarily the mu-receptor, resulting in characteristic morphine-like effects including analgesia, euphoria, sedation, respiratory depression, miosis, bradycardia and physical dependence. Because of the prolonged half-life of methadone compared to other morphine-like agents such as heroin, the onset of opiate withdrawal symptoms is slower, the duration of opiate withdrawal is prolonged, and opiate withdrawal symptoms are less severe.


brand name of an estrogen replacement drug


vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

Poly-Vi-Sol (Vitamin A 1500 UNT/ML / Vitamin D 400 UNT/ML / Vitamin E 5 UNT/ML / Vitamin C 35 MG/ML / Thiamin 0.5 MG/ML / Riboflavin 0.6 MG/ML / Niacin 8 MG/ML / Vitamin B6 0.4 MG/ML / Vitamin B 12 0.002 MG/ML) Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]

ascorbic acid 35 MG/ML / cholecalciferol 0.01 MG/ML / niacin 8 MG/ML / riboflavin 0.6 MG/ML / thiamine 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol]


vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

Poly-Vi-Sol with Iron (vitamin A 1500 UNT/ML / vitamin D 400 UNT/ML / vitamin E 5 UNT/ML / vitamin C 35 MG/ML / thiamin 0.5 MG/ML / riboflavin 0.6 MG/ML / niacin 8 MG/ML / vitamin B6 0.4 MG/ML / ferrous sulfate 50 MG/ML (iron 10 MG/ML)) Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

ascorbic acid 35 MG/ML / cholecalciferol 0.01 MG/ML / ferrous sulfate 50 MG/ML / niacin 8 MG/ML / riboflavin 0.6 MG/ML / thiamine 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution [Poly-Vi-Sol with Iron]


brand name of infliximab a drug used to treat autoimmune disorders


sulfabenzamide / sulfacetamide / sulfathiazole


A sodium salt form of sulfadiazine, an intermediate-acting bacteriostatic, synthetic sulfanilamide derivative.


sulfamethoxazole / trimethoprim Oral Suspension [Sulfatrim]


brand name of an antibiotic for cystic fibrosis treatment


brand name of a drug that is used to dissolve gallstones


A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION.


A sulfate salt form of abacavir, a nucleoside reverse transcriptase inhibitor analog of guanosine. This agent decreases HIV viral loads, retards or prevents the damage to the immune system, and reduces the risk of developing AIDS.


The aspartate salt of amphetamine, a sympathomimetic amine with CNS stimulating properties. Amphetamine acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from nerve terminals in the brain and inhibiting their uptake. Physiological effects include an increase in motor activity, euphoria, increased mental alertness, excitatory behavior, and appetite suppression.


The sodium salt of ceftazidime, a third-generation cephalosporin antibiotic with bactericidal activity. Ceftazidime binds to and inactivates penicillin-binding proteins (PBPs), enzymes located on the inner membrane of the bacterial cell wall, resulting in the weakening of the bacterial cell wall and cell lysis. Compared to the second and first generation cephalosporins, ceftazidime is more active against gram-negative bacteria and less active against gram-positive bacteria. Ceftazidine also crosses the blood-brain barrier and reaches therapeutic concentrations in the central nervous system (CNS). PBPs participate in the terminal stages of assembling the bacterial cell wall, and in reshaping the cell wall during cell division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity.


The sodium salt of cerivastatin, a synthetic lipid-lowering agent.


The orally bioavailable hydrobromide salt of the racemic bicyclic phthalene derivative citalopram with antidepressant activity. As a selective serotonin reuptake inhibitor (SSRI), citalopram selectively inhibits the CNS neuronal reuptake of serotonin, thereby potentiating serotonergic activity in the central nervous system (CNS). This agent has minimal effects on the CNS neuronal reuptake of norepinephrine (NE) and dopamine (DA).


A tricarboxylic acid found in citrus fruits. Citric acid is used as an excipient in pharmaceutical preparations due to its antioxidant properties. It maintains stability of active ingredients and is used as a preservative. It is also used as an acidulant to control pH and acts as an anticoagulant by chelating calcium in blood.


A liposome-encapsulated form of the citrate salt of the anthracycline antineoplastic antibiotic daunorubicin. Daunorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. Liposomal delivery of doxorubicin citrate improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects.


The saccharate salt form of the dextro-isomer of amphetamine, a synthetic substance related to natural sympathomimetic amines, with CNS stimulating properties. Dextroamphetamine saccharate acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from its storage sites in nerve terminals in the brain, and inhibits their uptake within the mesocorticolimbic system, a major component of the brain reward system, thereby resulting in measurable behavioral changes such as euphoria. As a CNS stimulant, this agent may increase blood pressure and reduce appetite. Similar to other amphetamines, dextroamphetamine has a high potential for abuse, dependence, and addiction if used in large doses over extended periods of time.


The difumarate salt form of emedastine, a second generation, selective histamine H1 receptor antagonist with anti-allergic activity. Emedastine reversibly and competitively blocks histamine by binding to H1 receptors, thus blocking its downstream activity. As a result, this agent interferes with mediator release from mast cells either by inhibiting calcium ion influx across mast cell/basophil plasma membrane or by inhibiting intracellular calcium ion release within the cells. In addition, emedastine may also inhibit the late-phase allergic reaction mediated through leukotrienes or prostaglandins, or by producing an anti-platelet activating factor effect. Upon ocular administration, emedastine causes a dose-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva. Emedastine does not affect adrenergic, dopamine, or serotonin receptors.


The sodium salt of enoxaparin, a low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, enoxaprin's mechanism of action is similar to that of heparin, although it exhibits a higher ratio of anti-Factor Xa to anti-Factor IIa activity. This agent also has anti-inflammatory properties, inhibiting monocyte adhesion to tumor necrosis factor alpha- or lipopolysaccharide-activated endothelial cells. Compared to unfractionated heparins, the use of enoxaparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia.


Coagulation factor IX (461 aa, ~52 kDa) is encoded by the human F9 gene. This protein plays a role in the intrinsic pathway of blood coagulation through the mediation of proteolysis that converts factor X into an active protease.


The acetate salt form of fluorometholone, a synthetic glucocorticoid with anti-inflammatory and anti-allergic properties. Fluorometholone acetate exerts its effect by interacting with cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions.


The acetate salt form of histrelin, a long-acting, synthetic nonapeptide analog of gonadotropin-releasing hormone (GnRH) with potential anti-tumor activity. Upon administration, histrelin binds to and activates GnRH receptors; prolonged administration results in pituitary GnRH receptor desensitization and inhibition of follicle stimulating hormone (FSH) and luteinizing hormone (LH) secretion, leading to a significant decline in testosterone production in males and may inhibit androgen receptor-positive tumor progression; in females, prolonged administration results in decreased estradiol production.


Regular insulin preparations that contain the SUS SCROFA insulin peptide sequence.


The succinate salt form of metoprolol, a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties and devoid of intrinsic sympathomimetic activity. Metoprolol succinate antagonizes beta 1-adrenergic receptors in the myocardium, thereby reducing the rate and force of myocardial contraction, and consequently a diminished cardiac output. This agent may also reduce the secretion of renin with subsequent reduction in levels of angiotensin II thus decreasing sympathetic activation, including vasoconstriction, aldosterone secretion.


The hydrochloride salt form of moricizine, a phenothiazine analog with class I antiarrhythmic activity. Moricizine hydrochloride blocks the rapid flow of sodium ions into the myocardial cell during phase 0 of the action potential. This decreases excitability, slows the impulse conduction through the atrioventricular (AV) node and depresses depolarization.


The calcium salt form of mupirocin, a natural crotonic acid derivative extracted from Pseudomonas fluorescens. Mupirocin inhibits bacterial protein synthesis by specific reversible binding to bacterial isoleucyl tRNA synthase. With excellent activity against gram-positive staphylococci and streptococci, it is primarily used for treatment of primary and secondary skin disorders, nasal infections, and wound healing. (NCI04)


A monohydrate form of nitrofurantoin, a synthetic derivative of imidazolidinedione (hydantoin) that inhibits bacterial DNA, RNA, and cell wall protein synthesis.


The acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Similar to somatostatin, this agent also suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone.


An opium tincture with antidiarrheal activity. The opiate morphine, in deodorized tincture of opium, increases the tone of the smooth muscle in the intestines. It stops the normal movement and slows down the passage of intestinal contents. This allows water to be absorbed from the liquid stool thereby decreasing diarrhea.


The acetate salt form of pirbuterol, a synthetic catecholamine and a pyridine derivative with sympathomimetic and bronchodilatory effects. Pirbuterol acetate selectively stimulates beta-2 adrenergic receptors, resulting in initiation of intracellular adenylate cyclase activity leading to increased levels of cAMP. As a result muscle relaxation (broncho- and vasodilation) occurs via cAMP-dependent signal transduction. In addition, elevated levels of cAMP inhibit release of inflammatory mediators from mast cells.


The fumarate salt form of quetiapine, a dibenzothiazepine derivative with antipsychotic property. Quetiapine fumarate antagonizes serotonin activity mediated by 5-HT 1A and 5-HT2 receptors. With a lower affinity, this agent also reversibly binds to dopamine D1 and D2 receptors in the mesolimbic and mesocortical areas of the brain leading to decreased psychotic effects, such as hallucinations and delusions. In addition, quetiapine fumarate also binds to other alpha-1, alpha-2 adrenergic and histamine H1 receptors.


A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION.


The sodium salt form of tazobactam, a penicillanic acid sulfone derivative and beta-lactamase inhibitor with antibacterial activity. Tazobactam contains a beta-lactam ring and irreversibly binds to beta-lactamase at or near its active site. This protects other beta-lactam antibiotics from beta-lactamase catalysis. This drug is used in conjunction with beta-lactamase susceptible penicillins to treat infections caused by beta-lactamase producing organisms.


A cationic surface-active compound. As an additive to pharmacologic formulations, thonzonium bromide causes dispersion and penetration of cellular debris and exudate, thereby promoting tissue contact of the administered medication.


The sodium salt form of tolbutamide, a short-acting, first-generation sulfonylurea with hypoglycemic activity. Compared to second-generation sulfonylureas, tolbutamide is more likely to cause adverse effects, such as jaundice. This agent is rapidly metabolized by CYPC29.


The tartrate salt form of tolterodine, a benzhydryl compound and a muscarinic receptor antagonist possessing both antimuscarinic and antispasmodic properties. Both tolterodine and its active metabolite, 5-hydroxymethyltolterodine, competitively blocks muscarinic receptors, thereby inhibiting acetylcholine receptor binding. This antagonistic action results in an increase in residual urine, reflecting an incomplete emptying of the bladder, and a decrease in detrusor pressure, indicating an antimuscarinic action on the lower urinary tract.. The 5-hydroxymethyl metabolite appears to contribute significantly to the therapeutic effects.


The sulfate salt form of trimethoprim, a synthetic substituted pyrimidine with antibacterial activity. Trimethoprim sulfate selectively binds to and reversibly inhibits dihydrofolate reductase, thereby blocking the production of tetrahydrofolic acid from dihydrofolic acid. This leads to an inhibition of bacterial synthesis of folic acid, thereby affecting nucleic acid and protein synthesis. Trimethoprim sulfate has a stronger binding affinity for the bacterial enzyme than for the corresponding mammalian enzyme.


The tartrate salt of an imidazopyridine with non-benzodiazepine benzodiazepine-receptor agonist and sedative-hypnotic activities. Zolpidem binds selectively to the alpha 1 subunit of the omega-1 (BZ1) receptor of the gamma-aminobutyric acid type A (GABA-A) receptor-chloride ionophore complex, thereby opening neuronal chloride channels, hyperpolarizing neuronal cell membranes, and inhibiting neuronal firing. In contrast, benzodiazepines non-selectively bind to and activate all omega receptor subtypes, exhibiting anticonvulsant and myorelaxant activities in addition to a sedative-hypnotic activity.


A tricarboxylic acid found in citrus fruits. Citric acid is used as an excipient in pharmaceutical preparations due to its antioxidant properties. It maintains stability of active ingredients and is used as a preservative. It is also used as an acidulant to control pH and acts as an anticoagulant by chelating calcium in blood.


A low viscosity liquid by-product of the distillation of petroleum consisting of a mixture of alkanes in the C15 to C40 range. Light mineral oil has uses in biotechnology, pharmaceutics, cosmetics, and industry.


A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.


Gram-negative, capsulated, gas-producing rods found widely in nature. Both motile and non-motile strains exist. The species is closely related to KLEBSIELLA PNEUMONIAE and is frequently associated with nosocomial infections


chlorhexidine hydrochloride 0.25 % / tolnaftate 1 % Topical Powder

chlorhexidine HCl 0.25 % / tolnaftate 1 % Topical Powder

chlorhexidine hydrochloride 0.0025 MG/MG / tolnaftate 0.01 MG/MG Topical Powder


An active metabolite of folic acid (also called folinic acid and citrovorum factor), which does not require metabolism by dihydrofolate reductase, the molecular target of folate antagonist-type chemotherapeutic drugs. Leucovorin calcium counteracts the toxic effects of these medications, 'rescuing' the patient while permitting the antitumor activity of the folate antagonist. This agent also potentiates the effects of fluorouracil and its derivatives by stabilizing the binding of the drug's metabolite to its target enzyme, thus prolonging drug activity. (NCI04)


dexamethasone sodium phosphate 0.1 % Ophthalmic Solution

dexamethasone phosphate 1 MG/ML Ophthalmic Solution


hepatitis B vaccine (recombinant) pediatric/adolescent (HepB) 5 MCG/0.5 ML Prefilled Syringe

hepatitis B surface antigen vaccine 5 MCG per 0.5 ML Prefilled Syringe

hepatitis B surface antigen vaccine 0.005 MG per 0.5 ML Prefilled Syringe

0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe


chloroquine phosphate 16 MG/ML (chloroquine 10 MG/ML) Oral Solution

chloroquine phosphate 16 MG/ML Oral Solution


atropine sulfate 1 MG per 5 ML Prefilled Syringe

5 ML atropine sulfate 0.2 MG/ML Prefilled Syringe


scopolamine 0.3336 MG/Day 72 HR Transdermal Patch

scopolamine 1 MG 3 Day Transdermal System

scopolamine 1.3 MG 3 Day Transdermal System

scopolamine 0.0139 MG/HR 72 HR Transdermal Patch

scopolamine 1.5 MG 3 Day Transdermal Patch

72 HR scopolamine 0.0139 MG/HR Transdermal System


dalteparin sodium 12,500 UNT in 0.5 ML Prefilled Syringe

dalteparin sodium 12,500 UNT per 0.5 ML Prefilled Syringe

0.5 ML dalteparin sodium 25000 UNT/ML Prefilled Syringe


dalteparin sodium 18,000 UNT in 0.72 ML Prefilled Syringe

dalteparin sodium 18,000 UNT per 0.72 ML Prefilled Syringe

0.72 ML dalteparin sodium 25000 UNT/ML Prefilled Syringe


dalteparin sodium 15,000 UNT per 0.6 ML Prefilled Syringe

dalteparin sodium 15,000 UNT in 0.6 ML Prefilled Syringe

0.6 ML dalteparin sodium 25000 UNT/ML Prefilled Syringe


metroNIDAZOLE 0.008 MG/MG Topical Gel
metroNIDAZOLE 0.8 % Topical Gel
metronidazole 0.8 % Topical Gel


0.5 ML Rebif 0.044 MG/ML Prefilled Syringe

Rebif 0.022 MG per 0.5 ML Prefilled Syringe

Rebif 22 MCG in 0.5 ML Prefilled Syringe

Rebif 22 MCG per 0.5 ML Prefilled Syringe

0.5 ML interferon beta-1a 0.044 MG/ML Prefilled Syringe [Rebif]


Exelon (as rivastigmine tartrate) 1.5 MG Oral Capsule

rivastigmine 1.5 MG Oral Capsule [Exelon]


Exelon (as rivastigmine tartrate) 3 MG Oral Capsule


Exelon (as rivastigmine tartrate) 4.5 MG Oral Capsule

rivastigmine 4.5 MG Oral Capsule [Exelon]


Exelon (as rivastigmine tartrate) 6 MG Oral Capsule


cycloSPORINE, modified 10 MG Oral Capsule

cyclosporine, modified 10 MG Oral Capsule


codeine phosphate 12.8 MG / acetaminophen 500 MG Oral Tablet

APAP 500 MG / Codeine Phosphate 12.8 MG Oral Tablet

acetaminophen 500 MG / codeine phosphate 12.8 MG Oral Tablet


A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT ISCHEMIC ATTACK patients.


Etopophos 100 MG (as etoposide phosphate) Injection


A radiolabelled urea molecule used to diagnose stomach ulcers caused by Heliobacter pylori. In the presence of H. pylori, urea C-13 is metabolized by urease to produce ammonia and radioactive carbon dioxide at the interface between the gastric epithelium and lumen. The radioactive carbon dioxide is absorbed in the blood and is detected when exhaled in the breath.


hylan G-F 20 16 MG in 2 ML Prefilled Syringe

hylan G-F 20 16 MG per 2 ML Prefilled Syringe

2 ML hylan G-F 20 8 MG/ML Prefilled Syringe


imiquimod 50 MG/ML Topical Cream [Aldara]


iloprost (as iloprost tromethamine) 0.1 MG/ML Injectable Solution


azithromycin 500 MG Oral Tablet [Zithromax]


tiaGABine hydrochloride 5 MG Oral Tablet

tiagabine hydrochloride 5 MG Oral Tablet


tiaGABine hydrochloride 10 MG Oral Tablet

tiagabine hydrochloride 10 MG Oral Tablet


tiaGABine hydrochloride 15 MG Oral Tablet

tiagabine hydrochloride 15 MG Oral Tablet


The sodium salt of the prodrug rabeprazole, a substituted benzimidazole proton pump inhibitor, with potential anti-ulcer activity. After protonation, accumulation, and transformation to the active sulfenamide within the acidic environment of gastric parietal cells, rabeprazole selectively and irreversibly binds to and inhibits the H+, K+ATPase (hydrogen-potassium adenosine triphosphatase) enzyme system located on the parietal cell secretory surface, inhibiting gastric acid secretion.


RABEprazole sodium 10 MG Delayed Release Oral Tablet

rabeprazole sodium 10 MG Delayed Release Oral Tablet


acetaminophen 60 MG Rectal Suppository
APAP 60 MG Rectal Suppository


Caverject 0.04 MG Injection
Caverject 40 MCG Injection

alprostadil 0.04 MG Injection [Caverject]


lithium succinate 80 MG/ML Topical Cream


dalteparin sodium 10,000 UNT in 1 ML Prefilled Syringe

dalteparin sodium 10000 UNT/ML 1 ML Prefilled Syringe

1 ML dalteparin sodium 10000 UNT/ML Prefilled Syringe


lidocaine HCl 5 % / phenylephrine HCl 0.5 % Topical Spray

lidocaine hydrochloride 50 MG/ML / phenylephrine hydrochloride 5 MG/ML Topical Spray


NIFEdipine 30 MG 24 HR Extended Release Oral Capsule

NIFEdipine 30 MG 24HR Extended Release Oral Capsule

24 HR NIFEdipine 30 MG Extended Release Oral Capsule

nifedipine 30 MG 24 HR Extended Release Oral Capsule

24 HR nifedipine 30 MG Extended Release Oral Capsule


24 HR NIFEdipine 60 MG Extended Release Oral Capsule

NIFEdipine 60 MG 24HR Extended Release Oral Capsule

nifedipine 60 MG 24 HR Extended Release Oral Capsule

NIFEdipine 60 MG 24 HR Extended Release Oral Capsule

24 HR nifedipine 60 MG Extended Release Oral Capsule


selegiline hydrochloride 1.25 MG Oral Tablet


ePHEDrine hydrochloride 3 MG/ML Injectable Solution

ephedrine hydrochloride 3 MG/ML Injectable Solution


dexamethasone 0.1 % / hypromellose 0.5 % Ophthalmic Solution

dexamethasone 1 MG/ML / hypromellose 5 MG/ML Ophthalmic Solution


chlorhexidine gluconate 0.225 % / cetrimide 2.25 % Topical Solution

cetrimide 2.25 % / chlorhexidine gluconate 0.225 % Topical Solution

cetrimide 22.5 MG/ML / chlorhexidine gluconate 2.25 MG/ML Topical Solution


ibuprofen 200 MG Extended Release Oral Capsule


nicotine (as nicotine cyclodextrin complex) 2 MG Sublingual Tablet


acetaminophen 120 MG / promethazine hydrochloride 1.5 MG per 5 ML Oral Suspension

APAP 24 MG/ML / Promethazine Hydrochloride 0.3 MG/ML Oral Suspension

acetaminophen 24 MG/ML / promethazine hydrochloride 0.3 MG/ML Oral Suspension


The hydrochloride salt form of levobunolol, a naphthalenone and non-cardioselective adrenergic beta-receptor antagonist with anti-glaucoma activity. Upon administration in the eye, levobunolol blocks beta-adrenergic receptors, thereby causing vasoconstriction. Levobunolol also decreases ciliary's body production of aqueous humor, leading to a decrease in aqueous humor.


The sodium salt form of cefoperazone and a semi-synthetic, broad-spectrum, beta-lactamase resistant, third-generation cephalosporin antibiotic with bactericidal activity. Cefoperazone sodium inhibits bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of bacterial cell walls. This results in a reduction of cell wall stability and causes cell lysis.


The hydrochloride salt form of fluoxetine, a diphenhydramine derivative and selective serotonin reuptake inhibitor with antidepressant, anti-anxiety, antiobsessional and antibulimic activity and with potential immunomodulating activity. Upon administration, fluoxetine binds to the presynaptic serotonin (5-HT) receptor resulting in negative allosteric modulation of the receptor complex, thereby blocking recycling of serotonin by the presynaptic receptor. Inhibition of serotonin reuptake by fluoxetine enhances serotonergic function through serotonin accumulation in the synaptic space, resulting in long-term desensitization and downregulation of 5-HT receptors, preventing 5-HT-mediated signaling and leading to antidepressant, anti-anxiety, antiobsessional and antibulimic effects. In addition, fluoxetine may inhibit the expression of pro-inflammatory cytokines, including interleukin-6 (IL-6). This may prevent IL-6-mediated inflammation and cytokine storm.


The orally bioavailable, acetate salt form of guanabenz, a centrally-acting alpha-2 adrenergic receptor agonist, with anti-hypertensive and potential antineoplastic, cytoprotective and bone resorption inhibitory activities. Upon oral administration, guanabenz suppresses endoplasmic reticulum (ER) stress by inhibiting the stress-induced dephosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2a), thereby enhancing the phosphorylation level of eIF2a. This causes elF2a-mediated downregulation of the Rac1 pathway, upregulates the expression of activating transcription factor 4 (ATF4), which plays a key role in osteoblastogenesis, and downregulates the expression of nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), which is a transcription factor that plays a key role in osteoclastogenesis. This enhances osteoblastogenesis and suppresses osteoclastogenesis. Altogether, this promotes new bone formation and prevents bone degradation. In addition, guanabenz blocks the proliferation, survival, motility and invasiveness of tumor cells through the eIF2a-mediated downregulation of Rac1 signaling. Rac1, a Ras-related small GTPase belonging to the Rho family, plays a key role in tumor cell proliferation, survival and motility.


The hydrochloride salt of the synthetic imidazothiazole derivative levamisole with anthelminthic and immunomodulating activities. In immunosuppressed states, levamisole may restore immune function by: 1) stimulating antibody formation, 2) stimulating T-cell activation and proliferation, 3) potentiating monocyte and macrophage phagocytosis and chemotaxis and 4) increasing neutrophil mobility, adherence, and chemotaxis.


The hydrochloride salt form of midodrine, a direct-acting prodrug and sympathomimetic agent with antihypotensive properties. Midodrine is converted to its active metabolite, desglymidodrine by deglycination reaction. Desglymidodrine selectively binds to and activates alpha-1-adrenergic receptors of the arteriolar and venous vasculature. This causes smooth muscle contraction and leads to an elevation of blood pressure. Desglymidodrine diffuses poorly across the blood-brain barrier, and is therefore not associated with effects on the central nervous system.


A naturally occurring antioxidant dicatechol originally derived from the creosote bush Larrea divaricatta with antipromoter, anti-inflammatory, and antineoplastic activities. Masoprocol directly inhibits activation of two receptor tyrosine kinases (RTKs), the insulin-like growth factor receptor (IGF-1R) and the c-erbB2/HER2/neu receptor, resulting in decreased proliferation of susceptible tumor cell populations. This agent may induce apoptosis in susceptible tumor cell populations as a result of disruption of the actin cytoskeleton in association with the activation of stress activated protein kinases (SAPKs). In addition, masoprocol inhibits arachidonic acid 5-lipoxygenase (5LOX), resulting in diminished synthesis of inflammatory mediators such as prostaglandins and leukotrienes. It may prevent leukocyte infiltration into tissues and the release of reactive oxygen species.


The mesylate salt of a synthetic imidazoline with alpha-adrenergic antagonist activity. As a competitive alpha-adrenergic antagonist, phentolamine binds to alpha-1 and alpha-2 receptors, resulting in a decrease in peripheral vascular resistance and vasodilatation. This agent also may block 5-hydroxytryptamine (5-HT) receptors and stimulate release of histamine from mast cells.


The sodium salt of fosinopril, a phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Fosinopril sodium is an ester prodrug that is hydrolysed by esterases to its active metabolite fosinoprilat. Fosinoprilat specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II, resulting in diminished vasopressor activity. In addition, angiotensin II-mediated aldosterone secretion by adrenal cortex is decreased, which results in a decrease of sodium retention and an increase of serum potassium. (NCI05)


A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.


brand name of a strong anti-inflammatory drug


The hydrochloride salt form of proparacaine, a benzoic acid derivative with local anesthetic property. Proparacaine hydrochloride stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thereby inhibiting sodium ion influx required for the initiation and conduction of impulses within the neuronal cell, and resulting in a loss of sensation.


The 17-valerate ester of betamethasone, a synthetic glucocorticoid with metabolic, immunosuppressive and anti-inflammatory actions. Betamethasone valerate binds to specific intracellular glucocorticoid receptors and subsequently binds to DNA to modify gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions.


A serine endopeptidase isolated from Bacillus subtilis. It hydrolyzes proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. It also hydrolyzes peptide amides. (From Enzyme Nomenclature, 1992) EC 3.4.21.62.


An over-the-counter herbal remedy, extracted from North American herb purple coneflower belonging to the Family Asteraceae, with potential immunostimulating and anti-inflammatory activities. Echinacea extract might be helpful to boost the body's immune system and to help fight infections, especially those of the upper respiratory tract. This herbal remedy seems to increase the growth and activity of immune cells, including white blood cells, macrophages and natural killer cells, and to stimulate phagocytosis. Furthermore, echinacoside, one of the components in Echinacea extract, has been shown to inhibit hyaluronidase, whose action increases tissue permeability, thereby Echinacea extract may promote tissue growth for wound healing by preventing bacteria spreading into healthy cells.


The hydrochloride salt form of dexmedetomidine, an imidazole derivate and active d-isomer of medetomidine with analgesic, anxiolytic and sedative activities. Dexmedetomidine selectively binds to and activates presynaptic alpha-2 adrenoceptors located in the brain, thereby inhibiting the release of norepinephrine from synaptic vesicles. This leads to an inhibition of postsynaptic activation of adrenoceptors, which inhibits sympathetic activity, thereby leading to analgesia, sedation and anxiolysis.


A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.


A steroidal compound with antiandrogen activity. Abiraterone inhibits the enzymatic activity of steroid 17alpha-monooxygenase (17alpha-hydrolase/C17,20 lyase complex; CYP17A1), a member of the cytochrome p450 family that catalyzes the 17alpha-hydroxylation of steroid intermediates involved in testosterone synthesis. Administration of this agent may suppress testosterone production by both the testes and the adrenals to castrate-range levels.


A synthetic derivative of hydroxyethylamine sulfonamide that selectively binds to and inhibits human immunodeficiency virus (HIV) protease.


An orally bioavailable, non-hormonal, multifunctional serotonin agonist and antagonist (MSAA) that may improve sexual desire and arousal in women. Upon oral administration, flibanserin selectively binds to serotonin receptors in the central nervous system, acting as an agonist on 5-HT1A receptors and an antagonist on 5-HT2A receptors. Agonist activity at 5-HT1A postsynaptic receptors may enhance the release of dopamine and other monoamines. Combined with 5-HT2A antagonism, flibanserin boosts levels of dopamine in the mesocortical area of the prefrontal cortex and produces a net increase of norepinephrine selectively in the prefrontal cortex through disinhibition of locus coeruleus noradrenergic neurons. In addition, flibanserin reduces concentrations of serotonin in the prefrontal cortex with chronic administration. Reducing serotonin, which modulates sexual activity in an inhibitory fashion through downstream decreases in dopamine release, while enhancing the release of norepinephrine and dopamine in the prefrontal cortex may improve sexual desire and interest.


The hydrochloride salt of a fluoroquinolone antibacterial antibiotic. Moxifloxacin binds to and inhibits the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV, resulting in inhibition of DNA replication and repair and cell death in sensitive bacterial species.


A synthetic 4-azasteroid compound. Dutasteride competitively and specifically binds to isoenzymes 1 and 2 of 5 alpha-reductase, forming stable enzyme complexes and inhibiting the conversion of testosterone to 5 alpha-dihydrotestosterone (DHT); the reduction in DHT activity may mitigate or prevent enlargement of the prostate gland. The type 2 5 alpha-reductase isoenzyme is primarily active in the reproductive tissues, while the type 1 isoenzyme is also active in skin and the liver.


A paramagnetic extracellular magnetic resonance imaging (MRI) contrast agent that facilitates visualization of abnormal vascularity. When placed in a magnetic field, gadoversetamide decreases T1 (spin-lattice or longitudinal relaxation time) and T2 (spin-spin or transverse relaxation time) values in tissues where it accumulates. At the recommended dose, the effect is primarily on T1 relaxation time, and produces an increase in signal intensity. Gadoversetamide does not cross the intact blood-brain barrier. However, abnormal vascularity or disruption of the blood-brain barrier allows accumulation of gadoversetamide. (NCI05)


A semi-synthetic derivative of pristinamycin, a natural occurring type B streptogramin. Quinupristin binds to the bacterial 50S ribosomal subunit, thereby inhibiting peptide chain elongation, and causing early termination of normal bacterial protein synthesis. Quinupristin is primarily effective against gram-positive cocci.


A semi-synthetic derivative of streptogramin A produced by streptomycetes. Dalfopristin inhibits the early phase of protein synthesis in the bacterial ribosome by binding to the 70S subunit, and also alters the configuration of the ribosome to make it more susceptible for streptogramin B binding. Dalfopristin is used in combination with quinopristin, a streptogramin B derivative. This combination is active against most gram-positive organisms, including Enterococcus faecium, and is also active against some gram-negative organisms and mycoplasma.


The essential oil extracted from juniper berries. Juniper berry oil is used in aromatherapy and perfumery.


A synthetic, nonsteroidal derivative of phenyl-furanone with antiinflammatory, antipyretic and analgesic properties and potential antineoplastic properties. Rofecoxib binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in an inhibition of the conversion of arachidonic acid to prostaglandins. COX-related metabolic pathways may represent key regulators of cell proliferation and neo-angiogenesis. Some epithelial tumor cell types overexpress pro-angiogenic COX-2. (NCI04)


A saturated fatty acid with a 15-carbon backbone. Pentadecylic acid is not normally synthesized by animals, but is found in trace amounts in dairy products.


A sterile suspension composed of an extract of bovine pulmonary surfactant with surfactant activity. Calfactant contains phospholipids, neutral lipids, and hydrophobic surfactant-associated proteins B (SP-B) and C (SP-C). Upon intratracheal administration, this agent, mimicking endogenous pulmonary surfactant, lines the alveoli and smallest bronchioles, keeping alveoli open during expiration by lowering surface tension. Resulting improvements in lung compliance and respiratory gas exchange may lead to improvements in ventilation and oxygenation.


A rexinoid (an RXR-binding ligand), tetrahydronaphthalene derivative and RETINOID X RECEPTOR antagonist that is used in the treatment of CUTANEOUS T-CELL LYMPHOMA.


A non-iodinated derivative of amiodarone that is used for the treatment of ARRHYTHMIA.


The carbonate salt of lanthanum, a silvery white metallic element of the lanthanoids family, with phosphate binding property. Lanthanum carbonate dissociates in gastric acid to release lanthanum ions, which then binds dietary phosphate. This agent inhibits the absorption of phosphate by forming highly insoluble lanthanum-phosphate complexes that reduce concentrations of serum phosphate and calcium phosphate.


A monoclonal antibody directed against the CD20 protein expressed on the surface of B-lymphocytes and radiolabeled with the radioisotope iodine I 131 with potential antineoplastic activity. Iodine I 131 tositumomab binds to and selectively delivers cyctotoxic radiation to CD20-expressing B-lymphocytes, thereby minimizing systemic radiotoxicity.


A greenish, crystalline inorganic compound that produces toxic gases upon heating. Nickel acetate is used in textile dyeing processes, in electroplating, and as a catalyst intermediate. Exposure to this substance can cause severe dermatitis, skin and asthma-like allergies and causes damage to the lungs, kidneys, gastrointestinal tract and neurological system. Nickel acetate is a known carcinogen and is associated with an increased risk of developing lung and nasal cancers. (NCI05)


The hydrochloride salt form of terazosin, a quinazoline derivative with adrenergic antagonistic property. Terazosin hydrochloride selectively inhibits alpha-1 adrenergic receptors, resulting in vasodilation leading to decreased peripheral vascular resistance and a reduced venous return to the heart as well as decreased urethral resistance, which potentially improving urine flow and symptoms related to benign prostatic hyperplasia. In addition, terazosin decreases low-density lipoproteins (LDL) and triglycerides while increasing the concentration of high-density lipoproteins (HDL).


The hydrochloride salt form of nicardipine, a synthetic derivative of nitrophenyl-pyridine and potent calcium channel blocker, Nicardipine (Nifedipine Family) blocks calcium ions from certain cell walls and inhibits contraction of coronary and peripheral arteries, resulting in lowered oxygen requirements for heart muscle and decreased arterial contraction and spasm. It is used clinically as a cerebral and coronary vasodilator. (NCI04)


The hydrochloride salt form of phenformin, an agent belonging to the biguanide class of antidiabetics with antihyperglycemic activity. Phenformin is not used clinically due to the high risk of lactic acidosis that is associated with its use.


The hydrochloride salt form of thiamine, a vitamin essential for aerobic metabolism, cell growth, transmission of nerve impulses and acetylcholine synthesis. Upon hydrolysis, thiamine hydrochloride is phosphorylated by thiamine diphosphokinase to form active thiamine pyrophosphate (TPP), also known as cocarboxylase. TPP is a coenzyme for many enzymatic activities involving fatty acid, amino acid and carbohydrate metabolism.


The hydrochloride salt form of a metal chelating agent with potential anti-angiogenic activity. Trientine chelates excess copper (Cu) ions in the body; the excess copper is subsequently removed from the body through the kidneys. As Cu is an essential cofactor for cuproenzymes, such as superoxide dismutase 1 (SOD1), depletion of copper may inhibit the activation of signal transduction pathways required for cellular proliferation and angiogenesis. In addition, trientine may inhibit copper-induced secretion of interleukin-8 (IL-8).


A phenylpiperidine with antidiarrheal activity and active metabolite of diphenoxylate. Difenoxin is chemically related to the narcotic opioid meperidine. Difenoxin hydrochloride acts primarily on the gastrointestinal wall by binding to opioid receptors on acetylcholine-containing nerves and inhibits the release of acetylcholine from presynaptic nerve terminals. This leads to a reduction in intestinal motility. Difenoxin hydrochloride also mimics the action of endogenous opioid peptides at the CNS opioid receptors, (primarily mu-receptors), thereby inducing CNS effects.


A preparation of hog pancreatic enzymes standardized for lipase content.


The hydrochloride salt form of anileridine, an opioid receptor agonist belonging to the piperidine class with analgesic activity. By binding to and activating opioid receptors in the central nervous sytem (CNS), anileridine mimics the endogenous opioids resulting in a decrease of nociceptve neurotransmitters and eventually an analgesic effect.


The hydrochloride salt of a natural alkaloid extracted from plants of the genus Pilocarpus with cholinergic agonist activity. As a cholinergic parasympathomimetic agent, pilocarpine predominantly binds to muscarinic receptors, thereby inducing exocrine gland secretion and stimulating smooth muscle in the bronchi, urinary tract, biliary tract, and intestinal tract. When applied topically to the eye, this agent stimulates the sphincter pupillae to contract, resulting in miosis; stimulates the ciliary muscle to contract, resulting in spasm of accomodation; and may cause a transitory rise in intraocular pressure followed by a more persistent fall due to opening of the trabecular meshwork and an increase in the outflow of aqueous humor.


The hydrobromide salt form of homatropine, a synthetic tertiary amine alkaloid with antimuscarinic properties. Homatropine, a competitive inhibitor of acetylcholine at the muscarinic receptor, blocks parasympathetic nerve stimulation. When applied topically to the eye, dilation of the pupil (mydriasis) and paralysis of accommodation (cycloplegia) result from the local anticholinergic effects on the ciliary muscle and iris.


Calcitonin (32 aa, ~3 kDa) is encoded by the human CALCA gene. This protein is involved in the modulation of blood calcium and phosphate concentrations through promoting incorporation of these ions into bone.


The sodium salt of hydrocortisone succinate with glucocorticoid property. Hydrocortisone sodium succinate is chemically similar to the endogenous hormone that stimulates anti-inflammatory and immunosuppressive activities, in addition to exhibiting minor mineralocorticoid effects. This agent binds to intracellular glucocorticoid receptors and is translocated into the nucleus, where it initiates the transcription of glucocorticoid-responsive genes, such as various cytokines and lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both potent mediators of inflammation.


An herbal extract derived from the root of the plant Glycyrrhiza glabra with potential anti-inflammatory, antioxidant, and antineoplastic activities. Licorice root extract contains glycoside glycyrrhizinic acid and numerous flavonoids. Glycyrrhizinic acid in licorice root extract is hydrolyzed to glycyrrhetic acid (GA); GA inhibits 11 beta-hydroxysteroid dehydrogenase, resulting in inhibition of the conversion of cortisol to the inactive steroid cortisone and elevated cortisol levels. In addition, GA inhibits 17,20-lyase and 17 beta-hydroxysteroid dehydrogenase, resulting in decreased conversions of 17-hydroxyprogesterone to androstenedione and androstenedione to testosterone. The primary antioxidant found in licorice root, the flavonoid glabridin, may inactivate or inhibit the activities of some cytochrome P450 enzymes. In tumor cells, beta-hydroxy-DHP, another flavonoid, may induce Bcl-2 phosphorylation, apoptosis, and G2/M cell cycle arrest.


The hydrochloride salt form of methacycline, a tetracycline antibiotic with broad-spectrum antibacterial and antiprotozoal activity. Methacycline hydrochloride is bacteriostatic and inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing the addition of amino acids to the growing peptide chain. This tetracycline is active against a wide range of gram-positive and gram-negative bacteria.


The hydrochloride salt of the biguanide metformin with antihyperglycemic and potential antineoplastic activities. Metformin inhibits complex I (NADPH:ubiquinone oxidoreductase) of the mitochondrial respiratory chain, thereby increasing the cellular AMP to ATP ratio and leading to activation of AMP-activated protein kinase (AMPK) and regulating AMPK-mediated transcription of target genes. This eventually prevents hepatic gluconeogenesis, enhances insulin sensitivity and fatty acid oxidation and ultimately leads to a decrease in glucose levels. Metformin may exert antineoplastic effects through AMPK-mediated or AMPK-independent inhibition of mammalian target of rapamycin (mTOR), which is up-regulated in many cancer tissues. Furthermore, this agent also inhibits tumor cell migration and invasion by inhibiting matrix metalloproteinase-9 (MMP-9) expression which is mediated through the suppression of transcription activator protein-1 (AP-1) activation.


The sulfate salt form of framycetin, an aminoglycoside antibiotic isolated from Streptomyces lavendulae (decaris), mainly containing neomycin B, with broad-spectrum antibacterial activity. Framycetin is used mostly as a topical preparation and is poorly absorbed. Upon parenteral administration, this agent can cause nephrotoxicity and ototoxicity.


The hydrochloride salt form of bepridil, a calcium antagonist and class IV anti-arrhythmic agent. Bepridil hydrochloride blocks calcium entry through membranous calcium channels of coronary and peripheral vascular smooth muscle, thereby dilating coronary arteries and peripheral arterioles. This increases oxygen delivery and reduces oxygen requirements. This drug is used to treat chronic stable and variant angina pectoris.


An alpha-1-adrenergic antagonist that acts by blocking alpha-adrenergic receptors in the smooth muscle of blood vessels (arteries, arterioles and veins), gastrointestinal tract, and radial smooth muscle of the iris. This prevents smooth muscle contraction and results in vasodilatation. Administered in the eye, dapiprazole hydrochloride produces miosis. In the heart, it may antagonize alpha-1 adrenoreceptors in myocytes causing a mild negative inotropic effect.